Engineering antibody therapeutics

Engineering antibody therapeutics

Item
http://www.wikidata.org/entity/Q26741445
Engineering Translation in Mammalian Cell Factories to Increase Protein Yield: The Unexpected Use of Long Non-Coding SINEUP RNAsTherapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Notch as a tumour suppressor.Using extensional flow to reveal diverse aggregation landscapes for three IgG1 molecules.Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells.Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents
P2860

Engineering antibody therapeutics

Item
http://www.wikidata.org/entity/Q26741445
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Engineering antibody therapeutics
@ast
Engineering antibody therapeutics
@en
Engineering antibody therapeutics
@nl
type
label
Engineering antibody therapeutics
@ast
Engineering antibody therapeutics
@en
Engineering antibody therapeutics
@nl
prefLabel
Engineering antibody therapeutics
@ast
Engineering antibody therapeutics
@en
Engineering antibody therapeutics
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P921
P3181
P356
P1433
P1476
Engineering antibody therapeutics
@en
P2093
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P921